Diabetic foot ulcers is caused by arterial insufficiency. The wearing of a total contact cast or a walking boot addresses the issue of unwanted mechanical pressures to the foot, but leads to disuse muscle atrophy, calf muscle pump dysfunction, and arterial insufficiency.
The VeinOPlus Vascular device improves arterial inflow to the lower extremities 4 times by delivering an electrical impulse to the calf muscle fibers every second. Each impulse mimics as if the patient is walking. VeinOPlus Vascular increases arterial inflow, accelerates healing of foot ulcers, and the patient’s quality of life is improved.
Venous Stasis Ulcers is caused by venous pooling due to incompetent valves and calf muscle pump dysfunction. Like above, the VeinOPlus Vascular device improves venous outflow 7 times, reduces edema, increases arterial perfusion, and accelerates healing of venous leg ulcers. Patients with a history of venous leg ulcers experience a recurrence rate of 72%. The VeinOPlus Vascular device effectively treats the underlying issues and helps prevent recurrence of venous ulcers.
VeinOPlus Vascular treats calf muscle pump dysfunction due to disuse muscle atrophy, improves blood flow to the lower extremities, and helps heal foot and leg ulcers.
VeinOPlus® is an ultra-portable electro-muscle stimulator programmed for improving blood flow in the lower limbs. The VeinOPlus® Vascular device weighs 24 grams and powered by a 9 volt battery.
VeinOPlus® technology utilizes proprietary electro-medicine technology developed by Dr. Cywinski, the holder of patents and over 100 scientific publications in the field of electrical stimulation of human tissue.
In Europe, over 250,000 patients suffering with venous and arterial insufficiency have been successfully treated with the VeinOPlus®, a Class II device approved by the FDA.
Each electrical impulse delivered by the VeinOPlus Vascular device causes the calf muscle to contract much the same that occurs when walking. Each minute, the device delivers 60 impulses with an automatic shut-off feature after sixty minutes of therapy. One-hour of therapy with the VeinOPlus is like taking 3,600 steps. Compliance is high due to ultra-portability, ease of use, and the impulse signal is comfortable. VeinOPlus therapy does not cause any increase in heart rate, measurable muscle ischemia, and/or pain.
Wearers of cardiac pacemakers and/or defibrillators should not use the VeinOPlus.
In June 2010, European Journal of Vascular Endovascular Surgery published a study titled “The Efficacy of a New [VeinOPlus®] Stimulation Technology Device to Increase Venous Flow and Prevent Venous Stasis“. The objectives of this study were to determine: (a) dependence of venous blood velocity and ejected volume rates of stimulated calf contractions and (b) clinical factors affecting efficacy in healthy individuals. This study concluded after more than 4,000 measurements that the VeinOPlus Vascular device is an effective method of activating the calf muscle pump. Secondly, the enhanced electrical signal patterns increased popliteal blood velocity and volume flow, arterial inflow, and in the prevention of venous stasis and DVT.
Conclusion: VeinOPlus is effective in activating the calf muscle pump. Enhancement of popliteal blood volume and velocity flow are key factors in improving circulation to the lower extremities.
In May 2013, The Journal of Vascular Surgery published a study titled “Calf muscle stimulation with the VeinOPlus® device results in a significant increase in lower limb inflow without generating limb ischemia or pain in patients with peripheral artery disease.” The aim of the study was to assess the effect of electrical stimulation of calf muscles on arterial inflow and tissue oxygen content in PAD patients.
Conclusion: Electrical stimulation of the calf muscle pump with the VeinOPlus® device results in a significant increase in arterial inflow without measurable muscle ischemia or pain.
In May 2011, International Angiology published a study titled “Electromuscular stimulation with VeinOPlus for the treatment of chronic venous edema.” The aim of the study was to evaluate the efficacy of the VeinOPlus and its impact on edema, pain, venous outflow, and patient’s quality of life.
Conclusion: VeinOPlus stimulation is an effective and well-tolerated therapeutic method for the treatment of chronic edema, for reducing pain, and improving the quality of life. The study showed VeinOPlus improves venous outflow and symptoms of CVI.
In March 2015, International Angiology published a study entitled “Electrical muscle stimulation with the VeinOPlus device in the treatment of venous ulcers.” The aim of the study was to analyze the results of electrical muscle stimulation usage in patients with venous ulcers.
Conclusion: VeinOPlus demonstrated high efficacy and good tolerability and provided significant reduction in pain severity, edema, and a 3-fold increase in healing venous stasis ulcers.
Take away message: Treating calf muscle pump dysfunction on a daily basis with the VeinOPlus Vascular device improves arterial and venous blood flow in lower extremities.